Journal of the Peripheral Nervous System

Papers
(The median citation count of Journal of the Peripheral Nervous System is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Abstracts323
60
33
33
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”27
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy24
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study19
PNS Abstracts 202319
Toxic medications in Charcot–Marie–Tooth patients: A systematic review18
Nerve ultrasound as a screening tool for inherited sensory neuronopathy17
16
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice16
Ofatumumab for treating autoimmune nodopathy16
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort15
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)14
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders13
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study13
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy12
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy12
Issue Information12
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)12
Issue Information11
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials11
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT11
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy10
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China10
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version9
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei9
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods9
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision9
Sensory neuronopathies: A case series and literature review9
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study9
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis8
Issue Information8
Nerve biopsy in acquired neuropathies8
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia8
Techniques for the standard histological and ultrastructural assessment of nerve biopsies8
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency7
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)7
Issue Information7
Issue Information7
Issue Information7
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A7
7
7
ABSTRACT6
Issue Information6
6
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers6
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy6
The autoimmune vulnerability of the node of Ranvier5
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”5
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po5
5
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy5
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease4
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy4
2021 Peripheral Nerve Society virtual event4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis4
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience4
4
Issue Information4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era4
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy4
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?4
Anxiety and depression in small fiber neuropathy4
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review3
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action3
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial3
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies3
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease3
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis3
3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy3
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study3
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort3
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation3
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies3
Issue Information3
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling3
Issue Information3
Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes2
Unusual upper limb features in SORD neuropathy2
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients2
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders2
2
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years2
Issue Information2
Abstract2
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN12
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review2
Identification of cellular and noncellular components of mature intact human peripheral nerve2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit2
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal2
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome2
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis2
Phase 2a randomized controlled study investigating the safety and efficacy of PDA‐002 in diabetic peripheral neuropathy2
2
Charcot‐Marie‐Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?2
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria2
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves2
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children2
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies2
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy2
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System2
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report1
Laura Feltri: In memoriam1
1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges1
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset1
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy1
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report1
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”1
Issue Information1
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents1
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review1
Sural nerve biopsy utility by masked assessment of individual histologic preparations1
Issue Information1
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy1
Normal structure and pathological features in peripheral neuropathies1
Serum neurofilament light chain measurements following nerve trauma1
1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy1
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A11
Issue Information1
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy1
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy1
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome1
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response1
Issue Information1
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome1
1
Issue Information1
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies1
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study1
Issue Information1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome1
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)1
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease1
Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropa1
Leptospirosis‐induced acute acquired inflammatory neuropathy1
1
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy1
Issue Information1
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?1
0.06341814994812